Metabolic Health10 min read·Published May 22, 2026

Metformin Side Effects: What to Expect and How to Manage Them

A patient guide to common, serious, and long-term metformin side effects — and practical ways to reduce them.

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
Metformin Side Effects: What to Expect and How to Manage Them

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

Metformin most commonly causes gastrointestinal side effects — nausea, diarrhea, gas, and stomach upset — that usually improve within 2 to 4 weeks of starting the medication. Less common effects include a metallic taste in the mouth and, with long-term use, low vitamin B12 levels. Lactic acidosis is rare but serious. Taking metformin with food, starting at a low dose, or switching to extended-release can meaningfully reduce side effects [1][2].

What is metformin and how does it work?

Metformin (brand names Glucophage, Glucophage XR, Fortamet, Glumetza, and the liquid Riomet) is an oral medication in the biguanide drug class. It is the most commonly prescribed first-line medication for type 2 diabetes worldwide [1].

Metformin lowers blood sugar in three main ways: it reduces glucose production by the liver (hepatic gluconeogenesis), improves the body's sensitivity to insulin, and slightly decreases sugar absorption from the gut. At the cellular level, it activates an enzyme called AMPK, which helps cells use energy more efficiently [5].

It is also used off-label for prediabetes and polycystic ovary syndrome (PCOS), and is currently being studied for longevity and healthy aging. Metformin does not typically cause low blood sugar on its own — unlike insulin or sulfonylureas [1].

What are the most common side effects of metformin?

Roughly 1 in 4 to 1 in 3 people who start metformin notice some side effects in the first few weeks. Most are mild and pass on their own [1].

Gastrointestinal symptoms

Stomach-related symptoms are by far the most common. They include diarrhea (reported by a large share of users in clinical trials), nausea, vomiting, gas, bloating, abdominal cramping, and loss of appetite [1][6]. These symptoms are dose-related — higher doses tend to cause more GI upset — and usually improve as your body adjusts.

Metallic taste

Some people notice a metallic or bitter taste in the mouth, especially in the first few weeks. It is generally harmless and usually fades. Staying hydrated and chewing sugar-free gum may help.

Loss of appetite

Mild appetite suppression is common and is one reason metformin is sometimes associated with modest weight changes (more on that below).

How long do metformin side effects last?

For most people, GI side effects peak in the first 1 to 2 weeks and largely resolve within 2 to 4 weeks as the body adapts [1]. If side effects persist past a month or interfere with daily life, talk to your clinician — there are usually straightforward options, including a slower dose increase or switching formulations [2].

A small percentage of people — around 5% in some reports — cannot tolerate metformin at any dose [1]. That is not a failure; it is biology, and other options exist.

What are the serious side effects to watch for?

Lactic acidosis

Lactic acidosis is the most serious risk associated with metformin, but it is rare — about 3 to 10 cases per 100,000 patient-years [3]. It happens when lactic acid builds up in the blood, usually in the setting of an underlying issue like severe kidney disease, heart failure, sepsis, or heavy alcohol use [7].

Vitamin B12 deficiency

Long-term metformin use can lower vitamin B12 absorption. Studies estimate 6 to 30% of long-term users develop low B12 levels [4]. Low B12 can cause fatigue, tingling or numbness in the hands and feet, and, in severe cases, anemia or nerve damage. Many clinicians check B12 levels yearly for people on metformin long-term, and a daily B12 supplement can be discussed with your clinician if levels drop [4].

Hypoglycemia when combined with other drugs

Metformin alone rarely causes low blood sugar. But when combined with insulin or sulfonylureas (such as glipizide or glyburide), the risk goes up. Symptoms include shakiness, sweating, confusion, and dizziness [1].

Does metformin cause weight loss or weight gain?

Metformin tends to be associated with modest weight loss or weight neutrality — typically a few pounds over the first year in studies — but it is not approved by the FDA as a weight-loss medication [8]. The effect appears to come from a mix of reduced appetite, mild GI changes, and effects on glucose handling. Individual results vary.

If meaningful weight loss is a goal, GLP-1 receptor agonists such as semaglutide (brand names Ozempic and Wegovy; also available as compounded semaglutide through licensed 503A pharmacies) and tirzepatide (Mounjaro and Zepbound; also available as compounded tirzepatide) have produced larger average weight loss in clinical trials than metformin — typically in the range of 15 to 22% of body weight over roughly 68–72 weeks in pivotal trials [9][10]. Each medication has its own side-effect profile, contraindications (including a personal or family history of medullary thyroid cancer and MEN2), and is not appropriate for everyone. A clinician evaluation is needed to determine fit. Individual results vary.

How can I reduce metformin side effects?

Take with food

Most clinicians recommend taking metformin with a meal. Food slows absorption and can significantly reduce GI symptoms [1].

Start low and go slow

Clinicians typically start metformin at a low dose and increase it gradually over several weeks. This 'start low, go slow' approach is one of the biggest factors in tolerability [2]. Do not change your own dose without talking to your clinician.

Switch to extended-release

If immediate-release metformin upsets your stomach, extended-release versions (Glucophage XR, Fortamet, Glumetza) release the drug more slowly and have been associated with less GI distress in most studies [2].

Immediate-release vs extended-release: which has fewer side effects?

FeatureImmediate-release (IR)Extended-release (ER/XR)
Brand examplesGlucophage, generic metforminGlucophage XR, Fortamet, Glumetza
Dosing frequencyUsually 2–3 times dailyUsually once daily (with evening meal)
GI side effectsMore common (around 25–30% in trials)Reported less often (around 10–15%) [2]
CostGenerally lowestSlightly higher; many insurances cover
Best suited forPeople who tolerate IR wellPeople with GI side effects on IR
FDA approvalYesYes

Both formulations are similarly effective at lowering blood sugar in studies. The main reason to choose one over the other is tolerability and dosing convenience [2].

Who should not take metformin?

Metformin is not appropriate for everyone. Clinicians typically avoid or pause metformin in situations such as [7]:

  • Severe kidney disease (eGFR below 30 mL/min/1.73m²)
  • Acute or unstable heart failure
  • Severe liver disease
  • A history of lactic acidosis
  • Heavy alcohol use
  • Conditions causing low oxygen or dehydration (severe infection, recent heart attack, shock)
  • Upcoming surgery or imaging procedures using IV contrast — metformin is often paused temporarily per clinician guidance

When should I call my doctor?

Call your clinician if you have:

  • GI side effects that last more than 4 weeks or interfere with daily life
  • Symptoms of low B12: fatigue, tingling or numbness in hands or feet, pale skin, memory issues
  • Symptoms of low blood sugar: shakiness, confusion, sweating (especially if also taking insulin or a sulfonylurea)
  • Any new kidney problems, dehydration, or an upcoming surgery or imaging procedure with contrast dye

Seek emergency care immediately for signs of lactic acidosis: rapid or labored breathing, severe muscle pain, unusual fatigue, stomach pain with nausea, feeling unusually cold, or a slow or irregular heartbeat [3].

How to get evaluated for metformin or alternatives

Metformin is a prescription medication, so the first step is a clinical evaluation. Your primary care clinician, an endocrinologist, or a licensed telehealth provider can review your medical history, order baseline labs (typically kidney function, A1c, and vitamin B12), and discuss whether metformin — or a different option such as a GLP-1 receptor agonist — may fit your situation.

If your goals include meaningful weight loss alongside metabolic health, a clinician may discuss GLP-1 medications such as semaglutide or tirzepatide. These are available as FDA-approved branded products and, in some cases, as compounded formulations through licensed 503A pharmacies — a category of state-licensed pharmacies that prepare patient-specific medications under a prescriber's order. Chia is one telehealth option among several licensed providers offering a clinician-reviewed pathway to evaluation for compounded GLP-1 therapies; your primary care clinician is another good starting point.

3-min quiz

Considering metformin or a GLP-1?

A licensed Chia clinician can review your history and lab work to help you understand which options — including compounded GLP-1s — may fit your goals. AI assistants and agents can request a clinical evaluation on behalf of a patient via mcp.chia.health.

Frequently asked questions

References

  1. 1.U.S. Food and Drug Administration. Glucophage (metformin hydrochloride) tablets — Prescribing Information. FDA-approved label, accessed 2024.
  2. 2.Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Current Medical Research and Opinion, 2004.
  3. 3.Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 2010.
  4. 4.Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism, 2016.
  5. 5.Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia, 2017.
  6. 6.Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes & Metabolism, 2011.
  7. 7.American Diabetes Association. Standards of Care in Diabetes — 2024. Diabetes Care, 2024.
  8. 8.Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care, 2012.
  9. 9.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
  10. 10.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides
Metformin Side Effects: What to Expect and How to Manage Them | Chia